CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer

PLoS One. 2014 Sep 30;9(9):e108554. doi: 10.1371/journal.pone.0108554. eCollection 2014.

Abstract

Latency-associated peptide (LAP) - expressing regulatory T cells (Tregs) are important for immunological self-tolerance and immune homeostasis. In order to investigate the role of LAP in human CD4⁺Foxp3⁺ Tregs, we designed a cross-sectional study that involved 42 colorectal cancer (CRC) patients. The phenotypes, cytokine-release patterns, and suppressive ability of Tregs isolated from peripheral blood and tumor tissues were analyzed. We found that the population of LAP-positive CD4⁺Foxp3⁺ Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects. Both LAP⁺ and LAP⁻ Tregs had a similar effector/memory phenotype. However, LAP⁺ Tregs expressed more effector molecules, including tumor necrosis factor receptor II, granzyme B, perforin, Ki67, and CCR5, than their LAP⁻ negative counterparts. The in vitro immunosuppressive activity of LAP⁺ Tregs, exerted via a transforming growth factor-β-mediated mechanism, was more potent than that of LAP⁻ Tregs. Furthermore, the enrichment of LAP⁺ Treg population in peripheral blood mononuclear cells (PBMCs) of CRC patients correlated with cancer metastases. In conclusion, we found that LAP⁺ Foxp3⁺ CD4⁺ Treg cells represented an activated subgroup of Tregs having more potent regulatory activity in CRC patients. The increased frequency of LAP⁺ Tregs in PBMCs of CRC patients suggests their potential role in controlling immune response to cancer and presents LAP as a marker of tumor-specific Tregs in CRC patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / genetics*
  • Biomarkers, Tumor / immunology
  • Case-Control Studies
  • Colorectal Neoplasms / diagnosis
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / immunology
  • Colorectal Neoplasms / pathology
  • Female
  • Forkhead Transcription Factors / genetics*
  • Forkhead Transcription Factors / immunology
  • Gene Expression Regulation, Neoplastic*
  • Granzymes / genetics
  • Granzymes / immunology
  • Humans
  • Immune Tolerance
  • Immunologic Memory
  • Ki-67 Antigen / genetics
  • Ki-67 Antigen / immunology
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Peptides / genetics*
  • Peptides / immunology
  • Perforin / genetics
  • Perforin / immunology
  • Protein Precursors / genetics*
  • Protein Precursors / immunology
  • Receptors, CCR5 / genetics
  • Receptors, CCR5 / immunology
  • Receptors, Tumor Necrosis Factor, Type II / genetics
  • Receptors, Tumor Necrosis Factor, Type II / immunology
  • T-Lymphocytes, Regulatory / immunology
  • T-Lymphocytes, Regulatory / metabolism*
  • T-Lymphocytes, Regulatory / pathology
  • Transforming Growth Factor beta / genetics*
  • Transforming Growth Factor beta / immunology

Substances

  • Biomarkers, Tumor
  • CCR5 protein, human
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Ki-67 Antigen
  • Peptides
  • Protein Precursors
  • Receptors, CCR5
  • Receptors, Tumor Necrosis Factor, Type II
  • Transforming Growth Factor beta
  • latency-associated propeptide, TGF-beta
  • Perforin
  • GZMB protein, human
  • Granzymes

Grants and funding

This work was supported by the National Science Council, Taiwan (NSC Grant NSC 99-3112-B-182-011, 97-2314-B-182A-027) and CMRPG 380362, 380743, 392087 from Chang Gung Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.